欧州連合 - ハンガリー語 - EMA (European Medicines Agency)

mylan ireland limited - fingolimod-hidroklorid - a sclerosis multiplex, a relapszáló-remittáló - immunszuppresszánsok - indicated as single disease modifying therapy in highly active relapsing remitting multiple sclerosis for the following groups of adult and paediatric patients aged 10 years and older: patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (for exceptions and information about washout periods see sections 4. 4 és 5. 1) or patients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain mri or a significant increase in t2 lesion load as compared to a previous recent mri.

欧州連合 - ハンガリー語 - EMA (European Medicines Agency)

laboratorios farmacéuticos rovi, s.a. - risperidone - skizofrénia - pszicholeptikumok - treatment of schizophrenia in adults for whom tolerability and effectiveness has been established with oral risperidone.

欧州連合 - ハンガリー語 - EMA (European Medicines Agency)

baxter holding b.v. - pemetrexed disodium heptahydrate - carcinoma, non-small-cell lung; mesothelioma - daganatellenes szerek - malignant pleural mesotheliomapemetrexed baxter in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed baxter in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5. pemetrexed baxter is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy (see section 5. pemetrexed baxter is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.

欧州連合 - ハンガリー語 - EMA (European Medicines Agency)

csl behring gmbh - etranacogene dezaparvovec - b hemofília - other hematological agents - treatment of severe and moderately severe haemophilia b (congenital factor ix deficiency) in adult patients without a history of factor ix inhibitors.

欧州連合 - ハンガリー語 - EMA (European Medicines Agency)

accord healthcare s.l.u. - dabigatran etexilát mesilate - venous thromboembolism; arthroplasty, replacement - antitrombotikus szerek - prevention of venous thromboembolic events.

欧州連合 - ハンガリー語 - EMA (European Medicines Agency)

sandoz gmbh - trastuzumab - breast neoplasms; stomach neoplasms - daganatellenes szerek - treatment of metastatic and early breast cancer and metastatic gastric cancer (mgc).

ハンガリー - ハンガリー語 - NÉBIH (Nemzeti Élelmiszerlánc-biztonsági Hivatal)

anti-germ hungary kereskedelmi kft. -

ハンガリー - ハンガリー語 - NÉBIH (Nemzeti Élelmiszerlánc-biztonsági Hivatal)

anti-germ hungary kereskedelmi kft. -

ハンガリー - ハンガリー語 - NÉBIH (Nemzeti Élelmiszerlánc-biztonsági Hivatal)

anti-germ hungary kereskedelmi kft. -

ハンガリー - ハンガリー語 - NÉBIH (Nemzeti Élelmiszerlánc-biztonsági Hivatal)

anti-germ hungary kereskedelmi kft. -